Jonathan Loaisiga's Deal With Yankees Makes D-backs' Bullpen Focus Clear

In this story:
On Thursday, reports began to surface that top right-handed reliever Jonathan Loaisiga would be returning to the New York Yankees on a two-year deal worth $18 million.
That contract, as expected, priced him out of the range of the Arizona Diamondbacks, who may be looking to reduce their payroll ahead of the 2027 season.
It was always a long shot to see Loaisiga return to the Diamondbacks, following an excellent 2.42 ERA, 67-inning season. But Arizona's bullpen has now seen the departure of multiple contributors.
Loaisiga is the first to sign officially, but Ryan Thompson, Kevin Ginkel, Dennis Santana and Taylor Clarke have all entered free agency, as has A.J. Puk, though Puk did not appear in a game during 2026.
With Loaisiga off the board, however, Arizona will likely have one main (realistic) re-sign option to focus on:
Diamondbacks could still retain Taylor Clarke after Loaisiga departure

Of the arms that have left in free agency, it feels unlikely to see a return by Ginkel, Thompson or Puk. Santana performed well, but was not a staple of Arizona's bullpen.
It's not out of the question to see any of these arms brough back, but the most realistic re-sign option is Clarke, whom the Diamondbacks have had reported interest in bringing back according to John Gambadoro.
Clarke, who returned to the Diamondbacks on a cheap one-year deal after spending three seasons with Arizona between 2019-2021, was an anchoring presence in the D-backs bullpen last season, pitching to a 2.96 ERA over the course of a career-high 71 appearances.
Clarke was a versatile weapon for Torey Lovullo; he appeared in middle innings, leverage situations and as an opener. At times he provided more than a full inning.
Despite that, his market will likely not be as high as Loaisiga's was. FanGraphs' crowdsourced estimate expects something in the realm of a one-year, $2 million deal, which would be a modest bump from 2026.
Even if that estimate is on the low end, a deal between $1 and $5 million is still doable for a quality pitcher, however.
But the Loaisiga deal also resigns Arizona to trusting in its young bullpen arms.
Diamondbacks will have to lean on young talent in 2027

Arizona is not without quality bullpen options, and they're going to have to take on an even larger role in 2027.
Lefty Brandyn Garcia, with a 1.93 ERA over 51-plus innings, emerged as one of the top relievers in the National League. Juan Morillo broke out for a 2.24 ERA in 64.1 innings. Justin Martinez returned from Tommy John surgery with a strong — but limited — 2.03 ERA output.
Even Gerardo Carrillo, despite ending his year with an ugly stretch, showed enough promise to suggest there may be a Morillo-like breakout waiting to happen. Lefty Andrew Saalfrank should be back from his shoulder injury, as well.
Losing a quality arm like Loaisiga is never a positive sign for a team's depth, but it will likely push them toward relying entirely on their young core of arms.

An Arizona native, Alex D'Agostino is the Publisher and credentialed reporter for Arizona Diamondbacks On SI. He previously served as Deputy Editor for Arizona Diamondbacks and Arizona Cardinals On SI and covered both teams for FanSided. Alex also writes for PHNX Sports. Follow Alex on X/Twitter @AlexDagAZ.
Follow alexdagaz